Abstract
Descending Necrotizing Mediastinitis is a rare complication that can be secondary to dental infections or surgical procedures involving the oral region. Despite a prompt pharmacological therapy and surgical intervention, a delayed diagnosis is still responsible for a too high mortality rate (about 40%). We present a review of the current literature on Descending Necrotizing Mediastinitis, focusing on the evolution of its management from Pearse to today. In particular, recent patents focused on novel compositions and methods to prevent and treat oral infections.
Keywords: Descending necrotizing mediastinitis, dental infections, oral infections, bacterial resistance, delayed diagnosis
Recent Patents on Anti-Infective Drug Discovery
Title: Descending Necrotizing Mediastinitis of Odontogenic Origin
Volume: 4 Issue: 2
Author(s): Matteo Biasotto, Silvia Chiandussi, Fulvia Costantinides and Roberto Di Lenarda
Affiliation:
Keywords: Descending necrotizing mediastinitis, dental infections, oral infections, bacterial resistance, delayed diagnosis
Abstract: Descending Necrotizing Mediastinitis is a rare complication that can be secondary to dental infections or surgical procedures involving the oral region. Despite a prompt pharmacological therapy and surgical intervention, a delayed diagnosis is still responsible for a too high mortality rate (about 40%). We present a review of the current literature on Descending Necrotizing Mediastinitis, focusing on the evolution of its management from Pearse to today. In particular, recent patents focused on novel compositions and methods to prevent and treat oral infections.
Export Options
About this article
Cite this article as:
Biasotto Matteo, Chiandussi Silvia, Costantinides Fulvia and Di Lenarda Roberto, Descending Necrotizing Mediastinitis of Odontogenic Origin, Recent Patents on Anti-Infective Drug Discovery 2009; 4 (2) . https://dx.doi.org/10.2174/157489109788490299
DOI https://dx.doi.org/10.2174/157489109788490299 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
Related Articles
-
Adipose-Derived Stromal/Stem Cells (ASC) in Regenerative Medicine: Pharmaceutical Applications
Current Pharmaceutical Design A Comprehensive Review on Ethnomedicinal, Pharmacological and Phytochemical Basis of Anticancer Medicinal Plants of Pakistan
Current Cancer Drug Targets Antibodies as Crypts of Antiinfective and Antitumor Peptides
Current Medicinal Chemistry Prevention and Treatment of Regimen-Related Mucosal Toxicity
Recent Patents on Anti-Cancer Drug Discovery Anti-TNF Antibodies in Inflammatory Bowel Disease: Do We Finally Know How it Works?
Current Drug Targets Pulmonary Valve Endocarditis: A Case Report
Infectious Disorders - Drug Targets Esophagitis, Treatment-Related Toxicity in Non-Small Cell Lung Cancer
Reviews on Recent Clinical Trials Anti-TNF and Postoperative Complications in Abdominal Crohn's Disease Surgery
Current Drug Targets Increased Serum HMGB-1, ICAM-1 and Metalloproteinase-9 Levels in Buerger’s Patients
Current Vascular Pharmacology The Role of Essential Oils and the Biological Detoxification in the Prevention of Aflatoxin Borne Diseases
Current Topics in Medicinal Chemistry Anti-Interleukin-6 Receptor Antibody Therapy in Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Extraction and Evaluation of Anti-inflammatory and Analgesic Activity of Mimosa rubicaulis in Swiss Albino Rats
Anti-Infective Agents Stress, Cardiovascular Diseases and Surgery-Induced Angiogenesis
Current Angiogenesis (Discontinued) Buccoadhesive Dosage Form Containing Antifungal Agent for Treating Oropharyngeal Candidiasis: A Review
Current Drug Therapy Concise Review of the Rationale for Pulmonary Embolism Treatment and Endovascular Device Therapies
Current Cardiology Reviews The Role of Magnetic Resonance Imaging in Detecting Intestinal Fibrosis in Crohn’s Disease
Current Drug Targets Gold - Old Drug with New Potentials
Current Medicinal Chemistry The Gut Microbiota in Inflammatory Bowel Disease
Current Pharmaceutical Design Management of Acute Aluminum Phosphide Poisoning: Has Anything Changed?
Drug Metabolism Letters Molecular Mechanisms of Restenosis After Percutaneous Peripheral Angioplasty and Approach to Endovascular Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders